BSE NSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Suven Life Sciences Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
530239
ISIN Demat
INE495B01038
Book Value (Rs)
38.7656699
NSE Symbol
SUVEN
Divident Yield %
0
Market Cap
(Rs In Cr.)
2,192
P/E (TTM)
0
EPS (TTM)
0
Face Value
(Rs)
1
Back
Suven Life Sciences reports consolidated net loss of Rs 26.54 crore in the March 2024 quarter
07-May-24   Hrs IST

Net Loss of Suven Life Sciences reported to Rs 26.54 crore in the quarter ended March 2024 as against net loss of Rs 27.64 crore during the previous quarter ended March 2023. Sales declined 8.43% to Rs 2.39 crore in the quarter ended March 2024 as against Rs 2.61 crore during the previous quarter ended March 2023.

For the full year,net loss reported to Rs 105.08 crore in the year ended March 2024 as against net loss of Rs 118.27 crore during the previous year ended March 2023. Sales declined 13.66% to Rs 11.69 crore in the year ended March 2024 as against Rs 13.54 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales2.392.61 -8 11.6913.54 -14
OPM %-1266.95-1207.66 --1095.04-929.76 -
PBDT-26.03-25.97 0 -107.04-117.72 9
PBT-27.54-27.64 0 -113.54-124.27 9
NP-26.54-27.64 4 -105.08-118.27 11

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)